Evidence map›Paper›PMID 41502999›Full record

ArticleWorld journal of nuclear medicine2025

[

Elife Akgün, Ümit Aksu, Arda Güler, Gamze Babur Güler, Meryem Kaya, Burcu Esen Akkaş

Abstract read
In one paragraph

Article in World journal of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elife AkgünDepartment of Nuclear Medicine, University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Istanbul, Türkiye.
Ümit AksuDepartment of Nuclear Medicine, University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.
Arda GülerDepartment of Cardiology, University of Health Sciences Türkiye, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.
Gamze Babur GülerDepartment of Cardiology, University of Health Sciences Türkiye, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.
Meryem KayaDepartment of Nuclear Medicine, University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.
Burcu Esen AkkaşDepartment of Nuclear Medicine, University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Association of [ Methods: Between September 2020 and December 2023, all [ Results: Among the 268 cases (147 females, 121 males; median age: 65), 12 (4.5%) were diagnosed with transthyretin (ATTR) CA and 19 (7.1%) with light chain (AL) CA. The median follow-up time was 386 days. ATTR CA cases exhibited significantly higher [ Conclusion: [

Indexed as

ALATTRcardiac amyloidosisprognosisPYPscintigraphy

Identifiers

PMID41502999
PMCPMC12774519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.